Trials / Conditions / Proximal Urethral Cancer

Proximal Urethral Cancer

9 registered clinical trials studyying Proximal Urethral Cancer.

Status	Trial	Sponsor	Phase
Terminated	Afatinib in Advanced Refractory Urothelial Cancer NCT02122172	University of Chicago	Phase 2
Terminated	Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cance NCT01611662	Fox Chase Cancer Center	Phase 2
Completed	Pazopanib in Treating Patients With Metastatic Urothelial Cancer NCT00471536	National Cancer Institute (NCI)	Phase 2
Completed	Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Functi NCT00478361	M.D. Anderson Cancer Center	Phase 2
Completed	VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium NCT00407485	National Cancer Institute (NCI)	Phase 2
Terminated	Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium NCT00112905	National Cancer Institute (NCI)	Phase 2
Terminated	Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothe NCT00004856	National Cancer Institute (NCI)	Phase 2
Completed	Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer NCT00021099	National Cancer Institute (NCI)	Phase 2
Completed	Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu NCT00004074	National Cancer Institute (NCI)	Phase 1